ORB-021
/ Orionis
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 27, 2026
OR2-01: ORB-021 In Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Orionis Biosciences Inc | Trial primary completion date: May 2026 ➔ Jan 2027
Trial primary completion date • Oncology • Solid Tumor
February 11, 2026
OR2-01: ORB-021 In Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Orionis Biosciences Inc | Trial primary completion date: Dec 2026 ➔ May 2026
Trial primary completion date • Oncology • Solid Tumor • PD-L1
January 06, 2025
OR2-01: ORB-021 In Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Orionis Biosciences Inc | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1